These results indicate a cell line-dependent pro-deathrole for the isolated PKC-δ C2 domain, highlighting that modulationof this domain, or its use as an autonomous pro-apoptotic agent, mayoffer new therapeutic avenues in breast cancer. This evidence concerns the gene PRKCD and breast carcinoma.